Figure 2.
Levels of anti–MGO-apoB100 (A) and anti–MGO-p5 (B) in type 1 diabetes with no/background retinopathy (n = 49) and proliferative retinopathy (n = 34). The values are presented as median (IQR). Absorbance was measured at 405 nm and is presented as absorbance units in percentage compared to control plasma pool. *P < 0.05 (Kruskal-Wallis test).
